3 Canadian healthcare stocks to keep on your radar

Be the First to Comment Read

3 Canadian healthcare stocks to keep on your radar

Follow us on Google News:
 3 Canadian healthcare stocks to keep on your radar
Image source: © 2021 Kalkine Media Inc      


  • The COVID-19 outbreak noticeably pulled investors’ focus to the healthcare sector.
  • A stock mentioned here has soared by more than 58 per cent in the last 12 months.
  • A healthcare company listed below posted a return on equity of 44.28 per cent

The COVID-19 outbreak noticeably pulled investors’ focus to the healthcare sector. But as the authorities began easing pandemic rules due to increased vaccination rates, investors also showed lesser interest in the healthcare space.

However, Ontario recently reported 454 new COVID cases, due to which it paused the plan to remove capacity limit in the remaining settings where vaccination proof is needed. This is likely to trigger a renewed interest in the healthcare sector.

Also read: Neighbourly Pharmacy (TSX:NBLY) stock soars post Q2 results. Buy alert?

That said, let us have a look at three Canadian healthcare stocks and their stock performance.

1.    Medical Facilities Corporation (TSX: DR)

Medical Facilities Corporation, also known as ‘MFC’, is a Toronto-headquartered  healthcare provider that owns and operates surgical facilities. It is also said to own controlling stakes in four speciality surgical hospitals and five ambulatory surgery centres.

On Wednesday, November 10, stocks of MFC were valued at C$ 9.56 per share, down by 2.548 per cent.

At this level, MFC stock noted a surge of about 15 per cent for the past three months. On a year-to-date (YTD) basis, it jumped by almost 36 per cent. It also soared by more than 58 per cent in the last 12 months.

Medical Facilities Corporation (TSX:DR)’s stock performance as of November 10, 2021 

Image source: © 2021 Kalkine Media Inc      

MFC posted a year-over-year (YoY) rise of 44.2 per cent in its facility service revenue of US$ 97.6 million in the second quarter of fiscal 2021. Its total revenue and other income, on the other hand, surged by 10.5 per cent YoY to US$ 98.1 million in Q2 FY2021.

On the valuation front, MFC held a price-to-book (P/B) ratio of 1.797 and a return on equity (ROE) of 6.43 per cent on November 11.

2.    Andlauer Healthcare Group Inc (TSX: AND)

Canadian investment holding firm Andlauer Healthcare Group Inc offers specialized transportation and healthcare logistics solutions.

The firm saw its scrip close at C$ 48.09 apiece on November 10, down by 0.435 per cent. Its scrip, at this point, climbed approximately 33 per cent in the last three months and marked a YTD growth of more than 17 per cent.

In the third quarter of fiscal 2021, Andlauer Healthcare Group (also known as AHG) recorded a YoY rise of 37.5 per cent in its revenue of C$ 104.2 million. Its net income amounted to C$ 12.2 million in the latest quarter, marking a YoY increase of 41.8 per cent.

At the time of writing this, AND stock posted an ROE of 44.28 per cent and a return on assets (ROA) of 15.33 per cent.

3.    Hamilton Thorne Ltd (TSXV: HTL)

Hamilton Thorne Ltd, headquartered in Beverly, is known to provide precision instruments, software and services solutions to assisted reproductive technologies (ART). It also serves the research and cell biology marketplace.

Stocks of Hamilton Thorne were valued at C$ 2.10 per share on November 10, up by 5.528 per cent. It clocked a day high of C$ 2.15 during the session.

HTL stock increased by nearly 17 per cent in the past month and swelled by about 50 per cent YTD. It also mounted by roughly 56 per cent in the last 12 months.

On the valuation side, Hamilton held a P/B ratio of 4.468 and an ROE of 5.44 per cent (as of November 11).

Also read: 3 top Canadian psychedelic stocks to buy 

Bottom line

The healthcare sector, a crucial part of a country’s economic growth and well-being, is always witnessing advancements. Investors should ideally keep an eye on such developments and innovations as these factors can help in the decision-making process when investing in an healthcare stock.


Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK